|
Help understanding GST-HG141 CAM
|
|
6
|
348
|
November 24, 2024
|
|
In appreciation of Hep B Foundation and online forums
|
|
3
|
926
|
October 13, 2024
|
|
Vote for Thomas Tu in the Sydney Awards
|
|
13
|
231
|
September 19, 2024
|
|
Enrolling in Arbutus trial PHASE2 - AB-729 + VTP-300 + nivolumab (Any thought or past exp)
|
|
5
|
643
|
September 13, 2024
|
|
POSITION AVAILABLE: Senior Project Officer for ASHM
|
|
0
|
495
|
June 22, 2021
|
|
Hepatitis B Story Writing Competition - Hepatitis NSW
|
|
0
|
599
|
August 3, 2021
|
|
Position Available: Service System Navigator
|
|
0
|
278
|
April 3, 2023
|
|
Travel Awards for ACH4 2023 Scientific Conference
|
|
0
|
234
|
September 29, 2023
|
|
Take the survey on Hepatitis B Clinical Trials and share your thoughts and opinions! ow.ly/gj7W50NuJkZ #hepatitisB #HepB #HBV
|
|
0
|
441
|
March 29, 2023
|
|
Hep B event at Parliament House in Canberra, Australia
|
|
0
|
472
|
February 5, 2022
|
|
World Hepatitis Day 2024
|
|
0
|
99
|
July 29, 2024
|
|
World Hepatitis Day Webinars 2024
|
|
2
|
205
|
July 19, 2024
|
|
WHO Global Webinar on 2024 WHO hepatitis B guidelines
|
|
2
|
355
|
July 29, 2024
|
|
Arbutus’ Imdusiran with Short Course Interferon Achieves Sustained Undetectable HBsAg
|
|
32
|
1269
|
July 1, 2024
|
|
B-Well,potential new treatment
|
|
6
|
1036
|
June 21, 2024
|
|
Tenofovir amibufenamide vs Vemlidy
|
|
5
|
896
|
April 18, 2024
|
|
Young Investigator Awards for Hepatitis Research
|
|
1
|
251
|
April 6, 2024
|
|
Position Available: Viral Hepatitis Peer Worker (Lived Experience)
|
|
0
|
253
|
April 2, 2024
|
|
Exploratory Hepatitis B dataset: Encouraging new hypotheses
|
|
4
|
496
|
March 31, 2024
|
|
VH2024: Abstract & Scholarship Opportunities
|
|
0
|
197
|
March 11, 2024
|
|
Health & Law Project
|
|
1
|
228
|
March 9, 2024
|
|
Community & Lived Experience Scholarships for VH2024
|
|
3
|
334
|
March 5, 2024
|
|
Positions Available at Hepatitis NSW
|
|
0
|
195
|
February 23, 2024
|
|
Position Available: Casual Multicultural Liver Health Worker
|
|
1
|
224
|
March 1, 2024
|
|
VIR-3434 Phase 1-study made by Vir Biotechnology
|
|
28
|
3311
|
December 21, 2023
|
|
Hep Q & A Night
|
|
1
|
278
|
December 4, 2023
|
|
Inaugural Meeting Progress on Hepatitis B Elimination in Canada
|
|
1
|
582
|
September 24, 2023
|
|
Ab-729 Trial, should I join?
|
|
81
|
4156
|
September 5, 2023
|
|
HBV International Meeting 4th Annual Community Forum
|
|
5
|
475
|
September 2, 2023
|
|
NMN supplement investigated as a potential cure - “Deregulated intracellular pathways define novel molecular targets for HBV-specific CD8 T cell reconstitution in chronic hepatitis B”
|
|
14
|
1922
|
August 19, 2023
|